All articles tagged with #glioblastoma
A Nature News & Views piece describes Koeber et al.'s strategy to selectively kill glioblastoma cells by using a virus to deliver an engineered DNA sequence that encodes a protein needed for a drug to kill the tumor, plus a cytokine to rally the immune system; in mice, this viral cargo eliminated brain tumours, offering a potential targeted cancer therapy that aims to spare healthy tissue.
A team created synthetic super-enhancers by assembling natural enhancer fragments bound by SOX2 and SOX9 in glioblastoma stem cells to achieve high, selective transgene expression. They packaged these SSEs into AAV vectors to drive a dual payload (HSV-TK/GCV cytotoxic system and IL-12) in a mouse glioblastoma model, achieving tumor clearance and immunological memory; SSE activity was validated in primary human GSCs and brain tissue slices, suggesting SSEs could enable cell-state-specific, potent gene therapy with broad applicability.
University of Calgary researchers are testing high-dose vitamin B3 (niacin) in addition to standard glioblastoma treatment. Early Phase I/II results in 24 patients show 82% progression-free at six months, a 28% improvement over historical data, suggesting niacin may restore immune function to attack tumors. Safety monitoring remains essential, and enrollment will expand to 48 participants by 2026–2027 to confirm benefits.
Mission Viejo couple Zak and Cori Salazar, both diagnosed with cancer in 2023, face ongoing battles—Zak with glioblastoma and Cori with pancreatic cancer—while raising three young daughters; they lean on grief-aware parenting, death-doula guidance, and a daily commitment to living fully, even as a scare over a brain MRI led to halting Zak's chemo after it proved to be a false alarm.
A phase 1 trial in 41 patients with recurrent glioblastoma found that a single injection of a modified herpes simplex virus can kill tumor cells and recruit enduring T cell activity into the tumor, correlating with longer survival than historical outcomes.
A 23-year-old medical student from Liverpool endured years of stroke-like episodes doctors dismissed as stress or health anxiety; after an emergency brain surgery in 2025, he was diagnosed with glioblastoma, an incurable brain cancer. Despite the delayed diagnosis, he underwent tumor removal and chemo/radiation; cancer later spread, and he is now traveling to Germany for cutting-edge immunotherapy while urging earlier scans for others with similar symptoms.
A 23-year-old medical student endured years of stroke-like episodes and fatigue that doctors repeatedly attributed to stress or health anxiety, with his father saying they visited about 50 doctors. A May 2025 episode led to emergency brain surgery that uncovered a 5 cm glioblastoma; prognosis is poor (12–18 months). He’s undergoing chemotherapy and radiation and is traveling to Germany for cutting-edge immunotherapy, as his family urges clinicians to take persistent symptoms in young people more seriously and push for earlier scans.
Becca Valle’s migraines led to a glioblastoma diagnosis. After tumor removal, she joined a focused ultrasound trial to temporarily open the blood-brain barrier to boost chemotherapy. In 34 participants, the approach showed a survival advantage, with up to 40% alive longer than expected; Valle has no evidence of disease four years later and says she’s living life to the fullest. The device and method are not yet FDA-approved and not widely available.
Researchers have developed a noninvasive nasal drop treatment using nanotechnology to target glioblastoma, an aggressive brain cancer, showing promising results in mice and potentially offering a safer, more effective therapy in the future.
Adam Hayden, a passionate advocate and writer who lived with terminal brain cancer for nine years, passed away at 43. His openness about his illness and dedication to raising awareness helped many, and his final days were marked by family, humor, and reflection on kindness. His story highlights the personal and systemic challenges faced by those with terminal illnesses.
A small study suggests that a supplement mix of resveratrol and copper may reduce the aggressiveness of glioblastoma brain tumors by altering cancer biomarkers, supporting a shift from traditional tumor-killing approaches to tumor healing and modulation of cancer biology. The treatment was well-tolerated with no side effects, but further research is needed to validate these findings.
Michael Bolton, diagnosed with glioblastoma in December 2023, is in very good health according to his daughters, who are his primary caregivers. Despite the challenges of his aggressive brain cancer and surgeries, Bolton remains strong and grateful, cherishing family moments and support from fans.
A preliminary study suggests that a combination of resveratrol and copper supplements may reduce markers associated with glioblastoma, an aggressive brain cancer, by targeting cell-free chromatin particles and immune response proteins, with ongoing clinical trials to determine their impact on patient survival.
Researchers have developed a noninvasive nasal nanotherapy using gold-based spherical nucleic acids that successfully eradicated glioblastoma tumors in mice by activating immune pathways, offering a promising new approach for treating deadly brain cancers.
The article discusses a novel implantable wafer system called CANDI that delivers immunostimulatory small molecules to reprogram immunosuppressive myeloid cells in glioblastoma, leading to long-term survival and prevention of tumor recurrence in mouse models, with promising implications for human treatment.